Related Experiment Videos
Summary
Cryopreserved human granulocytes maintain high recovery and bactericidal activity for up to 8 months. This study supports the feasibility of using cryopreserved granulocytes for transfusion therapy.
Area of Science:
- Immunology
- Cell Biology
- Cryobiology
Background:
- Granulocytes are crucial immune cells.
- Cryopreservation is essential for long-term storage of biological materials.
- Maintaining granulocyte function post-cryopreservation is vital for therapeutic applications.
Purpose of the Study:
- To evaluate the efficacy of cryopreservation for human granulocytes.
- To assess the impact of storage duration and phase (liquid vs. vapor) on granulocyte function.
- To determine the feasibility of cryopreserved granulocyte transfusion therapy.
Main Methods:
- Human granulocytes were isolated using dextran sedimentation.
- Cells were cryopreserved using controlled-rate freezing in dimethyl sulfoxide and autologous plasma.
- Samples were stored in liquid nitrogen (vapor or liquid phase) for up to 8 months.
- Cell recovery and bactericidal activity against Staphylococcus aureus were assessed.
- Transmission electron microscopy was used to examine cellular morphology.
Main Results:
- Mean cell recovery was 58% and mean bactericidal activity was 72% after storage.
- No significant decline in cell recovery or bactericidal activity was observed with prolonged storage (up to 8 months).
- Samples stored for over 8 months showed 73% cell recovery and 77% bactericidal activity.
- No advantage of liquid over vapor phase storage was detected.
- Electron microscopy revealed intact cell membranes and granules, with some nuclear changes.
Conclusions:
- Cryopreservation effectively maintains human granulocyte function for extended periods.
- Prolonged storage does not significantly impair granulocyte recovery or bactericidal capacity.
- Cryopreserved granulocytes show promise for transfusion therapy, offering a viable option for patients.